Search

everythinglearnresearchcommunity

for

Search:↓

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Alopecia areata in US adolescents leads to significant healthcare costs and usage.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

DNCB is more effective than betamethasone for hair regrowth but has more side effects.

Mirror-image twins can have alopecia areata on opposite sides of their heads.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Alopecia areata is common in young males and linked to stress.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Alopecia areata treatment should consider life quality and mental health, not just clinical results.

PRP injections can effectively treat alopecia areata.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

The SBN system effectively assesses alopecia areata severity and predicts its course.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Non-immune factors play a significant role in alopecia areata.